Literature DB >> 27866280

Proteasome-mediated degradation of tyrosine hydroxylase triggered by its phosphorylation: a new question as to the intracellular location at which the degradation occurs.

Akira Nakashima1, Yu Kodani2, Yoko S Kaneko2, Hiroshi Nagasaki2, Akira Ota2.   

Abstract

Tyrosine hydroxylase (TH) is the rate-limiting enzyme in catecholamine biosynthesis, and its stability is a fundamental factor to maintain the level of the catecholamines in cells. However, the intracellular stability of TH determined by the degradation remains unknown; although the TH molecule phosphorylated at its Ser19 was observed in the nucleus, and the phosphorylation suspected to trigger its proteasome-mediated degradation. Computer-assisted analysis using the cNLS Mapper program predicted that two sequences of nuclear localization signals (NLS) exist in the N-terminus of TH molecule containing the phosphorylation sites Ser19, Ser31, and Ser40 (Pro9-Arg38 and Lys12-Ile42): the NLS scores indicated that TH could become localized in both nucleus and cytoplasm. Moreover, inhibition of the importin α/β-mediated nuclear import pathway increased the level of TH phosphorylated at its Ser19 in PC12D cells. The results suggest that TH might be imported to nucleus from cytoplasm to be degraded. Recent studies revealed that proteasomes predominantly exist in the nucleus rather than in the cytoplasm to degrade the nuclear proteins related to cell-cycle progression, gene expression, DNA damage, and DNA repair. Therefore, these studies suggest that the relationship between the phosphorylation and the nuclear localization of the TH molecule should be a matter of focus to understand the mechanism of proteasome-mediated degradation of the enzyme as a first priority.

Entities:  

Keywords:  Importin; NLS; Nuclear import; Nuclear localization signals; Phosphorylation; Proteasome; Tyrosine hydroxylase

Mesh:

Substances:

Year:  2016        PMID: 27866280     DOI: 10.1007/s00702-016-1653-z

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  58 in total

1.  Crystal structure of tyrosine hydroxylase at 2.3 A and its implications for inherited neurodegenerative diseases.

Authors:  K E Goodwill; C Sabatier; C Marks; R Raag; P F Fitzpatrick; R C Stevens
Journal:  Nat Struct Biol       Date:  1997-07

2.  Similar temporal and spatial recruitment of native 19S and 20S proteasome subunits to transcriptionally active chromatin.

Authors:  Fuqiang Geng; William P Tansey
Journal:  Proc Natl Acad Sci U S A       Date:  2012-04-02       Impact factor: 11.205

Review 3.  Regulatory mechanism of tyrosine hydroxylase activity.

Authors:  Hitoshi Fujisawa; Sachiko Okuno
Journal:  Biochem Biophys Res Commun       Date:  2005-08-10       Impact factor: 3.575

4.  Phosphorylation adjacent to the nuclear localization signal of human dUTPase abolishes nuclear import: structural and mechanistic insights.

Authors:  Gergely Róna; Mary Marfori; Máté Borsos; Ildikó Scheer; Enikő Takács; Judit Tóth; Fruzsina Babos; Anna Magyar; Anna Erdei; Zoltán Bozóky; László Buday; Bostjan Kobe; Beáta G Vértessy
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2013-11-19

5.  Accumulation of phosphorylated tyrosine hydroxylase into insoluble protein aggregates by inhibition of an ubiquitin-proteasome system in PC12D cells.

Authors:  Ichiro Kawahata; Hirofumi Tokuoka; Hasan Parvez; Hiroshi Ichinose
Journal:  J Neural Transm (Vienna)       Date:  2009-09-12       Impact factor: 3.575

Review 6.  Strategic role of the ubiquitin-dependent segregase p97 (VCP or Cdc48) in DNA replication.

Authors:  Kristijan Ramadan; Swagata Halder; Katherine Wiseman; Bruno Vaz
Journal:  Chromosoma       Date:  2016-04-18       Impact factor: 4.316

7.  Dopamine-dependent neurotoxicity of alpha-synuclein: a mechanism for selective neurodegeneration in Parkinson disease.

Authors:  Jin Xu; Shyan-Yuan Kao; Frank J S Lee; Weihong Song; Lee-Way Jin; Bruce A Yankner
Journal:  Nat Med       Date:  2002-06       Impact factor: 53.440

8.  Angiotensin-(1-7) through AT receptors mediates tyrosine hydroxylase degradation via the ubiquitin-proteasome pathway.

Authors:  María A Lopez Verrilli; Carlos J Pirola; Mariano M Pascual; Fernando P Dominici; Daniel Turyn; Mariela M Gironacci
Journal:  J Neurochem       Date:  2009-01-22       Impact factor: 5.372

9.  Dopamine or biopterin deficiency potentiates phosphorylation at (40)Ser and ubiquitination of tyrosine hydroxylase to be degraded by the ubiquitin proteasome system.

Authors:  Ichiro Kawahata; Shiori Ohtaku; Yoshihisa Tomioka; Hiroshi Ichinose; Tohru Yamakuni
Journal:  Biochem Biophys Res Commun       Date:  2015-07-27       Impact factor: 3.575

10.  Activation and multiple-site phosphorylation of tyrosine hydroxylase in perfused rat adrenal glands.

Authors:  J W Haycock; A R Wakade
Journal:  J Neurochem       Date:  1992-01       Impact factor: 5.372

View more
  4 in total

1.  Role of endothelin receptor type A on catecholamine regulation in the olfactory bulb of DOCA-salt hypertensive rats: Hemodynamic implications.

Authors:  María J Guil; Mercedes I Schöller; Luis R Cassinotti; Vinicia C Biancardi; Soledad Pitra; Liliana G Bianciotti; Javier E Stern; Marcelo S Vatta
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2019-08-06       Impact factor: 5.187

Review 2.  Human tyrosine hydroxylase in Parkinson's disease and in related disorders.

Authors:  Toshiharu Nagatsu; Akira Nakashima; Hiroshi Ichinose; Kazuto Kobayashi
Journal:  J Neural Transm (Vienna)       Date:  2018-07-11       Impact factor: 3.575

3.  Rpt2 proteasome subunit reduction causes Parkinson's disease like symptoms in Drosophila.

Authors:  Iván Fernández-Cruz; Iván Sánchez-Díaz; Verónica Narváez-Padilla; Enrique Reynaud
Journal:  IBRO Rep       Date:  2020-07-11

4.  Single amino acid in V2 encoded by TYLCV is responsible for its self-interaction, aggregates and pathogenicity.

Authors:  Wenhao Zhao; Yinghua Ji; Shuhua Wu; Xiaofang Ma; Shuo Li; Feng Sun; Zhaobang Cheng; Yijun Zhou; Yongjian Fan
Journal:  Sci Rep       Date:  2018-02-23       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.